108 related articles for article (PubMed ID: 18198374)
1. Hepatitis C virus proteins interfere with the activation of chemokine gene promoters and downregulate chemokine gene expression.
Sillanpää M; Kaukinen P; Melén K; Julkunen I
J Gen Virol; 2008 Feb; 89(Pt 2):432-443. PubMed ID: 18198374
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression.
Kaukinen P; Sillanpää M; Kotenko S; Lin R; Hiscott J; Melén K; Julkunen I
Virol J; 2006 Sep; 3():66. PubMed ID: 16945160
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity.
Nitta S; Sakamoto N; Nakagawa M; Kakinuma S; Mishima K; Kusano-Kitazume A; Kiyohashi K; Murakawa M; Nishimura-Sakurai Y; Azuma S; Tasaka-Fujita M; Asahina Y; Yoneyama M; Fujita T; Watanabe M
Hepatology; 2013 Jan; 57(1):46-58. PubMed ID: 22911572
[TBL] [Abstract][Full Text] [Related]
4. Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection.
Brownell J; Bruckner J; Wagoner J; Thomas E; Loo YM; Gale M; Liang TJ; Polyak SJ
J Virol; 2014 Feb; 88(3):1582-90. PubMed ID: 24257594
[TBL] [Abstract][Full Text] [Related]
5. Importin β1 targeting by hepatitis C virus NS3/4A protein restricts IRF3 and NF-κB signaling of IFNB1 antiviral response.
Gagné B; Tremblay N; Park AY; Baril M; Lamarre D
Traffic; 2017 Jun; 18(6):362-377. PubMed ID: 28295920
[TBL] [Abstract][Full Text] [Related]
6. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.
Horner SM; Park HS; Gale M
J Virol; 2012 Mar; 86(6):3112-20. PubMed ID: 22238314
[TBL] [Abstract][Full Text] [Related]
7. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
Johnson CL; Owen DM; Gale M
J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
[TBL] [Abstract][Full Text] [Related]
8. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection.
Loo YM; Owen DM; Li K; Erickson AK; Johnson CL; Fish PM; Carney DS; Wang T; Ishida H; Yoneyama M; Fujita T; Saito T; Lee WM; Hagedorn CH; Lau DT; Weinman SA; Lemon SM; Gale M
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):6001-6. PubMed ID: 16585524
[TBL] [Abstract][Full Text] [Related]
9. Multiple NF-kappaB and IFN regulatory factor family transcription factors regulate CCL19 gene expression in human monocyte-derived dendritic cells.
Pietilä TE; Veckman V; Lehtonen A; Lin R; Hiscott J; Julkunen I
J Immunol; 2007 Jan; 178(1):253-61. PubMed ID: 17182562
[TBL] [Abstract][Full Text] [Related]
10. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.
Anggakusuma ; Brown RJP; Banda DH; Todt D; Vieyres G; Steinmann E; Pietschmann T
J Virol; 2016 Dec; 90(23):10670-10681. PubMed ID: 27654291
[TBL] [Abstract][Full Text] [Related]
11. Induction of high-molecular-weight (HMW) tumor necrosis factor(TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation.
Hassan M; Selimovic D; Ghozlan H; Abdel-Kader O
Cell Signal; 2007 Feb; 19(2):301-11. PubMed ID: 16916598
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functions.
Kaukinen P; Sillanpää M; Nousiainen L; Melén K; Julkunen I
J Med Virol; 2013 Jan; 85(1):71-82. PubMed ID: 23096996
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease.
Hiscott J; Lacoste J; Lin R
Biochem Pharmacol; 2006 Nov; 72(11):1477-84. PubMed ID: 16876765
[TBL] [Abstract][Full Text] [Related]
14. Double-stranded RNA-induced interferon-beta and inflammatory cytokine production modulated by hepatitis C virus serine proteases derived from patients with hepatic diseases.
Dansako H; Ikeda M; Ariumi Y; Wakita T; Kato N
Arch Virol; 2009; 154(5):801-10. PubMed ID: 19353241
[TBL] [Abstract][Full Text] [Related]
15. A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals.
Franco S; Clotet B; Martínez MA
Virus Res; 2008 Feb; 131(2):260-70. PubMed ID: 18037183
[TBL] [Abstract][Full Text] [Related]
16. Identification of amino acid variants in the hepatitis C virus non-structural protein 4A.
Bermúdez-Aguirre AD; Padilla-Noriega L; Zenteno E; Reyes-Leyva J
Tohoku J Exp Med; 2009 Jul; 218(3):165-75. PubMed ID: 19561386
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-γ production.
Brenndörfer ED; Brass A; Söderholm J; Frelin L; Aleman S; Bode JG; Sällberg M
Gut; 2012 Apr; 61(4):589-96. PubMed ID: 21813471
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.
Ahlén G; Derk E; Weiland M; Jiao J; Rahbin N; Aleman S; Peterson DL; Pokrovskaja K; Grandér D; Frelin L; Sällberg M
Gut; 2009 Apr; 58(4):560-9. PubMed ID: 18689426
[TBL] [Abstract][Full Text] [Related]
19. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.
Dansako H; Ikeda M; Kato N
FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms.
Cheng G; Zhong J; Chisari FV
Proc Natl Acad Sci U S A; 2006 May; 103(22):8499-504. PubMed ID: 16707574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
